Updated:
Eye & Ear Foundation of Pittsburgh
The Eye & Ear Foundation of Pittsburgh directs a $47M portfolio to seed early-stage hearing and vision therapies born at the University of Pittsburgh.
Eye & Ear Foundation of Pittsburgh
Founded in 1985, the Eye & Ear Foundation of Pittsburgh operates as the dedicated fundraising and investment vehicle for the Departments of Ophthalmology and Otolaryngology at the University of Pittsburgh School of Medicine. Under Board Chair Lawrence N. Gumberg, it channels philanthropic capital to bridge the gap between laboratory discovery and patient care at UPMC. The Henry L. Hillman Foundation provided a $20 million commitment, anchoring a life sciences research push. The foundation allocates its estimated $47 million portfolio across early-stage venture, seed, and growth investments with a focus on medical innovation. Investment activity is expressed through direct co-investment in faculty-led spin-outs and support for translational research centers. Confirmed initiatives include the Pittsburgh Hearing Institute, which collocates scientists and clinicians to develop novel tinnitus and hearing loss therapies, and Pittsburgh CREATES, a surgical innovation lab that partners with Carnegie Mellon University engineers to prototype next-generation robotic instrumentation. The geographic focus centers on the Pittsburgh life-sciences ecosystem, with clinical deployment through UPMC's regional network. The board combines real estate, medical, and operational expertise. Board members include Douglas P. Dick, CEO of Dick Building Company, and James L. Soffer, President of Soffer Organization. The foundation maintains two physical offices on the UPMC campus at 203 Lothrop Street and 1622 Locust Street, plus a mobile screening unit called the eyeVan. The foundation's explicit mandate is to accept the risk that federal grants will not, funding bold, high-reward research that requires private capital to reach the clinic. The foundation's structural posture is unusual: rather than making broad philanthropic grants, it operates as a strategic investment vehicle for a specific academic-medical partnership. This creates a built-in deal-flow pipeline from the university's faculty investigators, leveraging the clinical scale of UPMC to validate early-stage technologies. The governance model concentrates authority in a compact board, enabling rapid allocation decisions without the committee bloat typical of larger university endowments.
General information
Firm type
Endowment / Foundation
Year founded
1985
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Pittsburgh
Corporate office
203 Lothrop Street, Suite 251, Pittsburgh, PA 15213
Additional offices
1622 Locust Street, Pittsburgh, PA 15219
Principals
Lawrence N. Gumberg
Board Chair; President of LG Realty Advisors, Inc.
Douglas P. Dick
Board Member; CEO & Chair of Dick Building Company.
James L. Soffer
Board Member; President & CEO of Soffer Organization.
Sector focus
Frequently asked questions
Where does the Eye & Ear Foundation of Pittsburgh source its deal flow?
The foundation's deal flow originates directly from investigators at the University of Pittsburgh's Departments of Ophthalmology and Otolaryngology. Its physical proximity to research centers like Pittsburgh CREATES and the Pittsburgh Hearing Institute, housed on the UPMC campus, provides an in-house pipeline to early-stage surgical robotics, diagnostics, and therapeutic spin-outs.
What is the foundation's relationship with UPMC and the University of Pittsburgh?
It is a 501(c)(3) organization operating as the dedicated support and investment vehicle for two specific academic departments at the University of Pittsburgh School of Medicine. UPMC serves as the clinical partner, providing the patient population and care settings where foundation-supported research is ultimately deployed and validated.
Does the foundation make fund commitments or only direct investments?
The foundation primarily directs capital into direct co-investments and funding for translational research centers rather than acting as a traditional limited partner in venture funds. Its strategy is to bridge the 'valley of death' for faculty-led innovations that require private risk capital before they attract larger institutional or corporate backing.
How are investment decisions made at the Eye & Ear Foundation?
A compact board, chaired by Lawrence N. Gumberg, consolidates investment decision-making. The model avoids the layered committee structures common at larger foundations, allowing the foundation to move quickly on faculty-led opportunities without the delays of bureaucratic review.
What role does the Henry L. Hillman Foundation play?
The Henry L. Hillman Foundation is a major donor, providing a $20 million commitment to life sciences research. This capital forms a significant part of the grant money the foundation distributes to accelerate hearing and vision research.
What is the Pittsburgh Hearing Institute?
It is a research center founded by Peter Santa Maria, MD, PhD, designed to co-locate clinicians and scientists to create a rapid path from scientific discovery to clinical treatment. The foundation funds this work to push beyond the limitations of current hearing loss and tinnitus treatments, including funding high-risk research that federal grants might not cover.
Is the Eye & Ear Foundation of Pittsburgh a general grantmaker?
No. It is a narrowly focused investment vehicle dedicated exclusively to advancing research in ophthalmology and otolaryngology. It operates more like a strategic venture arm for two specific university departments than a general-purpose charitable foundation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: